Evotec SE (OTCMKTS:EVTCY – Get Free Report) shares crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $3.38 and traded as low as $2.96. Evotec shares last traded at $2.99, with a volume of 581,784 shares changing hands.
Evotec Trading Down 0.3%
The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57. The stock has a market capitalization of $1.03 billion, a P/E ratio of 7.63 and a beta of 0.98. The stock has a 50-day moving average price of $3.36 and a two-hundred day moving average price of $3.69.
Evotec Company Profile
Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.
The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.
See Also
- Five stocks we like better than Evotec
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Do you know what Amazon is planning for January 1?
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
